GlassScriptPhysician profile
Michelle Levy
NPI 1679653828
$998.99
in general payments reported to CMS, 2019-2025
15 companies · $34.60 in 2025
The $34.60 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $395 · 2020: $168 · 2021: $325 · 2022: $75.84 · 2025: $34.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $34.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $34.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $372.13 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $108.01 | 2019-2020 | |
| Tris Pharma INC | $85.08 | 2020-2022 | |
| Shire North American Group INC | $58.78 | 2019 | |
| Sobi, INC | $54.30 | 2019-2020 | |
| Corium, LLC | $53.69 | 2021-2022 | |
| Cranial Technologies, INC | $50.71 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.60 | 2020-2021 | |
| Stryker Corporation | $34.60 | 2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform |
| Neos Therapeutics, LP | $33.47 | 2019 | |
| Dermira, INC. | $33.00 | 2019-2020 | |
| Genentech USA, INC. | $28.69 | 2019-2020 | |
| Phadia US INC. | $15.21 | 2021 | |
| Glaxosmithkline, LLC. | $14.23 | 2022 | |
| Adlon Therapeutics L.P. | $11.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.